New drugs for colorectal cancer - Highlights of 2015 and 8 drugs to watch

December 10, 2015

|

Kim Harford

Colorectal cancer highlights of 2015

  • Tumours laden with more mutations may respond better to immunotherapy. Perhaps one of the more quoted studies of 2015 was the trial of Merck’s drug Keytruda, in colorectal cancer, which demonstrated that colorectal tumours with h...

Read More
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square
Recent Posts

New drugs for colorectal cancer - Highlights of 2015 and 8 drugs to watch

December 10, 2015

The role of NAD in cancer

December 9, 2015

Please reload

Archive

December 2015 (2)

Please reload

Search By Tags

BBI608

Biothera

Dandrit

Imprime PGG

NAD

NAD and cancer stem cells

ROS

T cell

T cell receptors

The role of NAD in cancer

UV

Xbiotech

adaptive

adenine

bbi503

boston biomedical

cancer

cancer prevention pharma

cancer stem cells

chlamydia

eflornithine

immune system

immuno-oncology

james watson

keytruda

leishmania

melcancervac

merck

nad

neratinib

niacin

nicotinamide adenine dinucleotide

nicotinamide and cancer

puma

reactive oxygen species

stem cells

sulindac

tb

toxoplasma gondii

tryptophan

tuberculosis

vitamin b3

watson

xilonix

Please reload

Orange 196x196.png

Cancerdata.com

  • Data in cancer

  • Store - buy reports

  • Asco-2020

  • Asco-esmo-19

  • Trends and all

  • Gastro-int

  • Asco all

  • Stock prices 2019

  • Database

  • About us

  • Esmo ov/gastric

  • Ovarian 2019 Asco Esmo

  • Asco liver

  • Asco highlights 2019 (old format)

  • Blood cancers

  • Esmo highlights18

  • Ash highlights 18

  • Asco highlights 2019 lymphoma (old)

  • Asco highlights 2019 colorectal (old)

  • Asco highlights 2019 gastric (old)

  • Asco highlights 2019 esophageal (old)

  • Asco highlights 2019 kidney (old)

  • ASCO highlights17

  • Online plans

  • More